US Stock MarketDetailed Quotes

FBIO Fortress Biotech

  • 2.4600
  • -0.1500-5.75%
Close Jul 24 16:00 ET
  • 2.4200
  • -0.0400-1.63%
Post 16:27 ET
50.21MMarket Cap-407P/E (TTM)

About Fortress Biotech Company

Fortress Biotech, Inc. engages in the manufacture and commercialization of novel pharmaceutical products and product candidates. It operates through the Dermatology Product Sales and Pharmaceutical and Biotechnology Product Development segments. Its products include Ximino, Targadox, Exelderm, Ceracade, and Luxamend. The company was founded in 2006 and is headquartered in Bay Harbor Islands, FL.

Company Profile

Company NameFortress Biotech
Listing DateDec 19, 2011
CEODr. Lindsay A. Rosenwald, M.D.
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address1111 Kane Concourse,Suite 301
CityBay Harbor Islands
CountryUnited States of America
Zip Code33154

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Lindsay A. Rosenwald, M.D.
  • Chairman of the Board, President and Chief Executive Officer
  • 1.12M
  • David Jin
  • Principal Accounting Officer, Chief Financial Officer and Head, Corporate Development; Interim Chief Financial Officer and Chief Operating Officer of Avenue Therapeutics
  • 1.32M
  • Dr. George C. Avgerinos, PhD
  • Senior Vice President, Biologics Operations
  • --
  • Michael S. Weiss
  • Director and Executive Vice Chairman, Strategic Development
  • 962.66K
  • Dr. Eric K. Rowinsky,M.D.
  • Co-Vice Chairman and Director
  • 175.07K
  • Dr. Lucy Lu, M.D.
  • Director
  • 40.03K
  • Malcolm Hoenlein
  • Independent Director
  • 45.03K
  • Kevin L. Lorenz, J.D.
  • Independent Director
  • 40.03K
  • J. Jay Lobell
  • Independent Director
  • 87.57K
  • Dov Klein
  • Independent Director
  • 120.06K
  • Dr. Jimmie Harvey, Jr,M.D.
  • Independent Director
  • 67.57K


Analyst Rating

No Data

Price Target

No Data

Heat List
Latest Price